JP Morgan Maintains Overweight on Replimune Group, Lowers Price Target to $39

JP Morgan analyst Anupam Rama maintains Replimune Group (NASDAQ:REPL) with a Overweight and lowers the price target from $47 to $39.

JP Morgan analyst Anupam Rama maintains Replimune Group (NASDAQ:REPL) with a Overweight and lowers the price target from $47 to $39.

Total
0
Shares
Related Posts